Search results for "Highlights"
H. pylori eradication therapy may lead to better outcomes for functional dyspepsia
A systematic review and meta-analysis found that Helicobacter pylori eradication therapy was associated with higher cure rates and rates of symptom improvement in H. pylori-positive patients with functional dyspepsia.
https://gastroenterology.acponline.org/archives/2022/01/28/2.htm
28 Jan 2022
NAFLD progression associated with increased mortality risk
Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021
Transportation, patient education among factors affecting colonoscopy rates after abnormal FIT, survey finds
Primary care physicians and staff were asked to identify patients' barriers to completing colonoscopy after an abnormal fecal immunochemical test (FIT) result, as well as factors that made completion more likely.
https://gastroenterology.acponline.org/archives/2021/08/27/2.htm
27 Aug 2021
Spotlight on Helicobacter pylori treatment
A review found that susceptibility-guided therapy may be the superior first-line treatment for H. pylori infection in areas with high antibiotic resistance, while a study of trial participants with 26.5 years of follow-up showed that H. pylori eradication may provide long-term protection against gastric cancer.
https://gastroenterology.acponline.org/archives/2022/04/22/5.htm
22 Apr 2022
U.S. sees increase in alcohol-associated liver disease mortality
Deaths from alcohol-associated liver disease increased among men and women, across all ages, and in all racial/ethnic populations in the U.S. from 2017 through 2020, leading researchers to call for a nationwide effort to reduce national alcohol consumption, improve screening, and optimize early treatment.
https://gastroenterology.acponline.org/archives/2022/03/25/2.htm
25 Mar 2022
Self-administered questionnaire may help evaluate patients' cirrhosis knowledge
The questionnaire, which covered medication use and accessibility, medication obstacles, lactulose use, diuretic use, beta-blocker use, and dietary sodium use, was validated in a study of 582 outpatients and 131 inpatients.
https://gastroenterology.acponline.org/archives/2022/09/23/1.htm
23 Sep 2022
Bentonite hemostatic powder noninferior to standard care for GI bleeding
In a single-blind randomized controlled trial, bleeding was controlled within 30 days in 90.1% of adults with acute nonvariceal bleeding on upper GI endoscopy assigned to receive TC-325 versus 81.4% of those assigned to standard treatment.
https://gastroenterology.acponline.org/archives/2021/12/17/3.htm
17 Dec 2021
AGA releases new guidance on coagulation disorders in patients with cirrhosis
A clinical practice guideline from the American Gastroenterological Association (AGA) suggested against extensive preprocedural testing in patients with stable cirrhosis who are undergoing routine GI procedures, among other recommendations.
https://gastroenterology.acponline.org/archives/2021/11/19/3.htm
19 Nov 2021
Severe COVID-19 associated with more IBS, less constipation
A prospective multicenter study found that patients hospitalized for COVID-19 had significantly higher rates of irritable bowel syndrome (IBS) and fewer problems with constipation at 12 months than controls.
https://gastroenterology.acponline.org/archives/2022/12/23/1.htm
23 Dec 2022
Guidance issued on pharmacologic treatment of chronic idiopathic constipation
The joint clinical practice guideline from the American Gastroenterological Association and the American College of Gastroenterology reviewed evidence on fiber, osmotic laxatives, stimulant laxatives, secretagogues, and a serotonin type 4 agonist.
https://gastroenterology.acponline.org/archives/2023/05/26/1.htm
26 May 2023